Neogen Corp. (NEOG)
9.195
-0.18
(-1.87%)
USD |
NASDAQ |
Jan 13, 16:00
9.00
-0.20
(-2.12%)
After-Hours: 19:35
Neogen Research and Development Expense (Annual): 21.09M for May 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Teleflex, Inc. | 161.67M |
| AbbVie, Inc. | 8.315B |
| Myriad Genetics, Inc. | 113.40M |
| Amgen, Inc. | 5.676B |
| Outlook Therapeutics, Inc. | 27.78M |